Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level.

Carlo TortiVincenzo ScaglioneBruno Mario CesanaChiara CostaNadia MarascioElisabetta SchiaroliChiara BustiSabrina BastianelliMazzitelli MariaEnrico Maria TrecarichiDaniela Francisci

Published in: Health science reports (2021)

The reduction in mean PCSK9 level from baseline pretherapy to after HCV eradication was statistically significant. Whether PCSK9 is a new biomarker for cardiovascular risk in these patients remains to be ascertained.

Keyphrases

hepatitis c virus infection
low density lipoprotein
end stage renal disease
ejection fraction
newly diagnosed
hepatitis c virus
chronic kidney disease
patient reported outcomes